NCT01085214 · OUTCOME

Changes in Bone Marrow Microenvironment

AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma · Source last updated 2015-08-19

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Baseline to up to 20-30 hours after receiving the first dose of AZD6244

What was measured

Effect of AZD6244 on the bone marrow microenvironment in MM.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

description: Effect of AZD6244 on the bone marrow microenvironment in MM.
reporting Status: NOT_POSTED
time Frame: Baseline to up to 20-30 hours after receiving the first dose of AZD6244
title: Changes in Bone Marrow Microenvironment
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice